Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000155434 | SCV000205124 | benign | not specified | 2013-09-11 | criteria provided, single submitter | clinical testing | Val15Leu in Exon 01D of TJP2: This variant is not expected to have clinical sign ificance because it has been identified in 1.5% (21/1384) of African American ch romosomes from a broad population by the NHLBI Exome Sequencing Project (http:// evs.gs.washington.edu/EVS; dbSNP rs73450853). |
Athena Diagnostics | RCV000993329 | SCV001146192 | benign | not provided | 2019-03-22 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000993329 | SCV001819881 | likely benign | not provided | 2018-07-31 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000993329 | SCV005226443 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003917527 | SCV004729551 | benign | TJP2-related disorder | 2019-03-15 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |